Skip to main content
With aesthetic clinics working towards opening from 4th July 2020, this page has been created to provide the latest key information from the Government and professional regulated bodies within the industry as well as our tips.

FACE MASKS | HAND SANITISERS | GLOVES | APRONS

STAY SAFE DURING COVID-19

Due to government instructions, all personal protective equipment is currently VAT Free

Aesthetics Guidelines

Government Guidelines

Public Health England & NHS Resources on COVID-19 Prevention

Finance

Patient

Clinic

Rapid COVID-19 Antibody Diagnostic Test

This in-vitro diagnostic device (IVD) is for healthcare professional use only and not regulated for home use.

This rapid point-of-care antibody blood test detects two types of antibodies - IgG (past infection) and IgM (current/recent infection).

  • Clinical Sensitivity (Accuracy for COVID-19 antibody detection) – 98.66%*
  • Clinical Specificity – 99.82%
  • Rapid result with simple finger prick in approximately 10 minutes.
  • Easy on-site testing for yourselves, your staff and your patients.
  • CE certified.
  • MHRA approved for sale and healthcare professional use.

*Clinical Sensitivity based on clinical data study carried out on 1000 individuals at 14 days or more following onset of symptoms. The MHRA Target Product Profile requirements (as of 20.05.2020) for COVID-19 Antibody tests is a clinical study carried out on a sample size of a minimum of 200 individuals, 98% for both Clinical Sensitivity and Clinical Specificity on specimens collected 20 days or more following onset of symptoms. Clinical Sensitivity is the positive detection of COVID-19 IgG antibodies, these antibodies begin production at days 10-14 days following onset of symptoms and this increases incrementally, therefore this test exceeds the MHRA requirements

  • Knowing if you, your colleagues or your patients have had Coronavirus.
  • Helping to ensure a safe working environment.
  • Enabling you to offer additional services to your patients.

For optimum results, the test should be performed at 14 days or more following onset of symptoms. If a positive test result is obtained and there is a concern about a current infection, we advise performing a PCR Swab Test and seeking medical advice.

The MHRA guidance in relation to the rapid point-of-care type of COVID-19 Antibody Tests such as the one we are supplying has not changed as these tests are being used in line with their CE certification, the approved sample type i.e. capillary blood extracted through a finger-prick blood sample and their approved intended use i.e. by a healthcare professional in a professional capacity.

So Yes, this test we are supplying is MHRA approved to be used with a finger-prick blood sample and to be carried out by a healthcare professional in a professional capacity only i.e. the test should not be re-sold to a patient for them to carry out themselves as this test is not approved for home use.

In light of recent MHRA guidance (published 28.05.2020) the guidance in relation to the rapid point-of-care type of COVID-19 Antibody Tests such as this test remains unchanged.

The recent published guidance and changes are in relation to laboratory-based COVID-19 Antibody Tests that were originally granted MHRA approval to be used with a venous blood sample and to be carried out by a healthcare professional. These laboratory-based COVID-19 Antibody Tests were instead marketed and sold by companies to be carried out by the patient at home (not by a healthcare professional in a professional capacity) using a finger-prick blood sample (not venous blood) and sent to the laboratory for analysis. Therefore, these tests were being used off-label and not covered by their CE certification which invalidated the granted approval. The MHRA has therefore temporarily stopped sales of these laboratory-based tests until further validation of the sample collection kits and the sample type is carried out to support how companies which to market their intended use.

Cookie Policy

Church Pharmacy uses cookies to improve your browsing experience. If you continue, we'll assume that you are happy to receive cookies from our website, although you can change your browser's cookie settings at any time. Find out more.

 

Back to top